These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27722534)

  • 41. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
    Bozdag M; Alafeefy AM; Altamimi AM; Carta F; Supuran CT; Vullo D
    Bioorg Med Chem; 2017 May; 25(10):2782-2788. PubMed ID: 28389112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T; Meignan S; Foulon C; Six P; Gros A; Bal-Mahieu C; Supuran CT; Scozzafava A; Frédérick R; Masereel B; Depreux P; Lansiaux A; Goossens JF; Gluszok S; Goossens L
    Bioorg Med Chem; 2013 Mar; 21(6):1451-64. PubMed ID: 23168081
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Carbonic anhydrase inhibitors: X-ray crystal structure of a benzenesulfonamide strong CA II and CA IX inhibitor bearing a pentafluorophenylaminothioureido tail in complex with isozyme II.
    Di Fiore A; De Simone G; Menchise V; Pedone C; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1937-42. PubMed ID: 15780637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.
    Martin DP; Cohen SM
    Chem Commun (Camb); 2012 May; 48(43):5259-61. PubMed ID: 22531842
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tricyclic sulfonamides incorporating benzothiopyrano[4,3-c]pyrazole and pyridothiopyrano[4,3-c]pyrazole effectively inhibit α- and β-carbonic anhydrase: X-ray crystallography and solution investigations on 15 isoforms.
    Marini AM; Maresca A; Aggarwal M; Orlandini E; Nencetti S; Da Settimo F; Salerno S; Simorini F; La Motta C; Taliani S; Nuti E; Scozzafava A; McKenna R; Rossello A; Supuran CT
    J Med Chem; 2012 Nov; 55(22):9619-29. PubMed ID: 23067387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functionalization of fluorinated benzenesulfonamides and their inhibitory properties toward carbonic anhydrases.
    Dudutienė V; Zubrienė A; Smirnov A; Timm DD; Smirnovienė J; Kazokaitė J; Michailovienė V; Zakšauskas A; Manakova E; Gražulis S; Matulis D
    ChemMedChem; 2015 Apr; 10(4):662-87. PubMed ID: 25758852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.
    Čapkauskaitė E; Zubrienė A; Smirnov A; Torresan J; Kišonaitė M; Kazokaitė J; Gylytė J; Michailovienė V; Jogaitė V; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2013 Nov; 21(22):6937-47. PubMed ID: 24103428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
    Pinard MA; Lotlikar SR; Boone CD; Vullo D; Supuran CT; Patrauchan MA; McKenna R
    Bioorg Med Chem; 2015 Aug; 23(15):4831-4838. PubMed ID: 26068018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
    Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
    J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
    Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A
    J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
    D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
    J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate: towards new carbonic anhydrase glycoinhibitors.
    Ombouma J; Vullo D; Supuran CT; Winum JY
    Bioorg Med Chem; 2014 Nov; 22(22):6353-9. PubMed ID: 25438758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases.
    Riafrecha LE; Rodríguez OM; Vullo D; Supuran CT; Colinas PA
    Bioorg Med Chem; 2013 Mar; 21(6):1489-94. PubMed ID: 23010455
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of novel isatin-based sulfonamides with potent and selective inhibition of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Güzel-Akdemir Ö; Akdemir A; Karalı N; Supuran CT
    Org Biomol Chem; 2015 Jun; 13(23):6493-9. PubMed ID: 25967275
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
    Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
    J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
    Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
    Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfamide derivatives with selective carbonic anhydrase VII inhibitory action.
    Villalba ML; Palestro P; Ceruso M; Gonzalez Funes JL; Talevi A; Bruno Blanch L; Supuran CT; Gavernet L
    Bioorg Med Chem; 2016 Feb; 24(4):894-901. PubMed ID: 26795114
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X-ray crystallographic studies.
    Temperini C; Cecchi A; Boyle NA; Scozzafava A; Cabeza JE; Wentworth P; Blackburn GM; Supuran CT
    Bioorg Med Chem Lett; 2008 Feb; 18(3):999-1005. PubMed ID: 18162396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.